Clinical trial
A Phase II, Multicentre, Double-blinded, Randomised, Cross-over Study to Evaluate Efficacy, Safety and Pharmacokinetics of Biostate® in Subjects With Haemophilia A.
NCT00879541 is registered in ClinicalTrials.gov with CSL Behring as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Multicentre, Double-blinded, Randomised, Cross-over Study to Evaluate Efficacy, Safety and Pharmacokinetics of Biostate® in Subjects With Haemophilia A.
- Lead sponsor
- CSL Behring
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 28, 2009
- Completion date
- October 31, 2010
- Enrollment
- 81 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.